Privia Health Group, Inc. (PRVA)

Environment story

Privia Health is a healthcare services company with limited disclosed environmental impact metrics. No Scope 1, Scope 2, or Scope 3 emissions data are publicly disclosed in available filings. The company does not appear to have published a formal net-zero target or decarbonization strategy. As a physician-enablement and medical group management company, environmental footprint is primarily indirect (healthcare delivery operations of affiliated practices). No major environmental controversies, resource depletion issues, toxic waste incidents, or water consumption controversies are documented in SEC filings or public reporting. The company's technology platform and remote capabilities (virtual visits, virtual scribes) theoretically reduce travel-related emissions, but quantified impact is not disclosed. Absence of environmental data disclosure results in substantial scoring deduction per rubric.

Social story

Privia Health demonstrates moderate social performance. The company emphasizes physician autonomy, provider retention (96% multi-year contract retention rate, 90%+ practice collections predictability), and has expanded its provider base to 5,380 implemented providers as of end-2025. No documented major union-suppression activities, NLRB complaints, or strikes within the last 24 months are disclosed. Leadership diversity metrics are not explicitly disclosed in the 10-K filing; executive/board composition percentages are not provided, creating a scoring limitation. CEO-to-median-worker pay ratio is not disclosed. The company's model emphasizes provider autonomy and fair market value compensation structures (Stark Law and Anti-Kickback Statute compliance). No major supply-chain human-rights controversies (e.g., cobalt mining, forced labor) are documented; the company's supply chain is primarily composed of healthcare delivery partners and technology vendors. No significant labor litigation or union disputes are disclosed. Diversity and pay equity commitments are not explicitly stated in available documents.

Governance story

Privia Health's governance structure is not fully disclosed in the 10-K filing. Board independence percentage is not explicitly stated; no dual-class share structure is mentioned, suggesting single-vote-per-share equity. The company is subject to extensive healthcare regulatory oversight (Stark Law, Anti-Kickback Statute, HIPAA, FCA compliance) and has disclosed no recent antitrust fines, SEC enforcement actions, or consumer-protection consent decrees. The company does not disclose its annual lobbying expenditures in the 10-K; no evidence of active lobbying to weaken climate regulation or consumer-protection statutes is documented. The company emphasizes compliance frameworks and internal controls but notes history of legal/regulatory risks inherent to healthcare operations. Risk disclosures are detailed and comprehensive, reflecting appropriate governance awareness. Governance score reflects lack of explicit board independence disclosure and absence of lobbying transparency, partially offset by detailed risk factor analysis and compliance orientation.

These are Missionomics' own editorial scores — directional signals built from disclosed facts under a published method, not certifications or definitive ratings of Privia Health Group, Inc.. Coverage and confidence vary by data point, and figures can lag real-world changes. Read the full Methodology for sourcing, scoring, and correction details — or open Privia Health Group, Inc. in the app for interactive charts and portfolio building.

More in Healthcare